Researcher
Jerome HENDRIKS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Adaptive immunology, Autoimmunity, Inflammation, Innate immunity, Cell signalling, Transcription and translation, Neurosciences not elsewhere classified, Immunomodulation therapy, Molecular and cell biology not elsewhere classified
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2009 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Oct 2009 → Today - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2007 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Oct 2007 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Sep 2004 → 31 Dec 2019
Projects
1 - 10 of 44
- Fatty acid elongation and desaturation in control of lesion progression and repair in multiple sclerosis.From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Phagocyte energy metabolism as target to induce remyelination in multiple sclerosis.From1 Jan 2024 → TodayFunding: Foundations, funds and other with scientific goal
- Enhancing lesion repair in multiple sclerosis: the therapeutic potential of nutritional compoundsFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- A novel target to boost OPC maturation and remyelination in multiple sclerosisFrom1 Nov 2023 → TodayFunding: FWO fellowships
- Reprogramming macrophage fatty acid metabolism to induce repair in multiple sclerosisFrom1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- Phloretin in treatment of neuroinflammatory and demyelinating diseases: further insights in regulatory aspects in food market accessFrom1 Apr 2023 → 31 Mar 2024Funding: IOF - technology concept exploration
- Targeting fatty acid synthesis to induce remyelination in MS.From1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- A phloretin-based nutraceutical to promote lesion repair in multiple sclerosis.From1 Nov 2022 → TodayFunding: BOF - doctoral mandates
- Targetting fatty acid synthesis as a therapy to promote remyelination in MSFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- LipoMacs: functional Lipidomics to unlock Macrophage-mediated therapyFrom1 Oct 2022 → TodayFunding: FWO Strategic Basic Research (SBO)
Publications
81 - 90 of 121
- Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses(2013)
Authors: Sofie CARMANS, Jerome HENDRIKS, Helena Slaets, Kristof THEWISSEN, Piet STINISSEN, Jean-Michel RIGO, Niels HELLINGS
Pages: 45 - 53 - Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis(2013)
Authors: Marijke Stevens, Silke TIMMERMANS, Astrid Bottelbergs, Jerome HENDRIKS, Bert BRONE, Myriam Baes, Jan Tytgat
Pages: 21 - 28 - Phosphatidylserine alters the functional properties of myelin-phagocytosing macrophages by activating PPARs(2012)
Authors: Jeroen BOGIE, Winde JORISSEN, Jo MAILLEUX, Piet STINISSEN, Niels HELLINGS, Jerome HENDRIKS
Pages: 37 - 37 - Interleukin-6 class cytokines regulate the development of inflammatory CNS lesions(2012)
Authors: Kris JANSSENS, Leen SLAETS, Jerome HENDRIKS, Helga de Vries, Bart Vanwijmeersch, Bert OP 'T EIJNDE, Chris van den Haute, Veerle Baekelandt, Piet STINISSEN, Niels HELLINGS
Pages: 142 - 142 - Identification of Protein Networks Involved in the Disease Course of Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis(2012)
Authors: Annelies VANHEEL, Ruth DANIELS, Stephane Plaisance, Kurt BAETEN, Jerome HENDRIKS, Pierre Leprince, Debora DUMONT, Johan ROBBEN, Bert BRONE, Piet STINISSEN, et al.
- Interleukin-6 class cytokines regulate the development of inflammatory CNS lesions(2012)
Authors: Niels HELLINGS, Kris JANSSENS, Jerome HENDRIKS, H. de Vries, B. Vanwijmeersch, Bert OP 'T EIJNDE, C. Van den Haute, Veerle Baekelandt, Piet STINISSEN, H. Slaets
Pages: 31 - 31 - Myelin-Derived Lipids Modulate Macrophage Activity by Liver X Receptor Activation(2012)
Authors: Jeroen BOGIE, Silke TIMMERMANS, V. Huynh-Thu, A. Irrthum, H.J.M. Smeets, J.A. Gustafsson, K.R. Steffensen, M.T. Mulder, Piet STINISSEN, Niels HELLINGS, et al.
- Liver X receptors regulate cholesterol homeostasis in oligodendrocytes(2012)
Authors: Katherine NELISSEN, Monique Mulder, Ilse SMETS, Silke TIMMERMANS, Karen SMEETS, Marcel AMELOOT, Jerome HENDRIKS
Pages: 60 - 71 - IMMUNOMODULATORY AND THERAPEUTIC PROPERTIES OF LIF IN MULTIPLE SCLEROSIS(2011)
Authors: Kris JANSSENS, Leen SLAETS, Veerle Baekelandt, C. Van den Haute, B. Vanwijmeersch, Bert OP 'T EIJNDE, Piet STINISSEN, Jerome HENDRIKS, Niels HELLINGS
Pages: S140 - S140 - Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation(2011)
Authors: Jeroen BOGIE, Piet STINISSEN, Niels HELLINGS, Jerome HENDRIKS